4:21 PM Jul 13, 2018

Pause for politics

The near record-setting pace of 1H18 capital markets activity isn’t likely to be replicated this half, but that won’t be because of changes to sector fundamentals. Instead, it’s likely the...

2:52 PM Jul 13, 2018

Roche’s partnering priority

As James Sabry gets set to lead partnering for all of Roche pharma, his first order of business might be to build out the company’s late-stage pipeline ahead of an impending patent cliff that...

3:59 PM Jul 12, 2018

HEAL-ing pain at NIH

In a move that could change how pain is studied and treated, NIH is planning a series of projects to build a platform for translational research that is more predictive and reproducible than the...

11:52 AM Jul 12, 2018

All-in-one viruses

Having taken its lead oncolytic virus into the clinic, PsiOxus Therapeutics Ltd. is building an immuno-oncology platform that uses engineered versions of the vector to selectively target multiple...

11:35 AM Jul 12, 2018

Making patients partners

FDA has rolled out the first of a series of planned guidance documents aimed at creating a road map for making patient experience data integral to every phase of medical product development.

1
2
3
4
5

Latest News

5:17 PM Jul 13, 2018

Democrats report on Novartis, Cohen inquiry

While Novartis AG (NYSE:NVS; SIX:NOVN) has admitted to bidding Michael Cohen for access to the Trump...

4:51 PM Jul 13, 2018

Roivant’s urology subsidiary files for $150M IPO

Urovant Sciences Ltd. (London, U.K) proposed Friday to raise up to $150 million in an IPO on NASDAQ...

4:28 PM Jul 13, 2018

RXR a potential minimal residual disease target in melanoma

New research into the biology of solid tumor minimal residual disease (MRD) has revealed retinoid X...

3:41 PM Jul 13, 2018

Management tracks: Human Longevity, Clementia

Human Longevity Inc. (San Diego, Calif.) said Chief of Radiogenomics David Karow will become interim CEO...

3:22 PM Jul 13, 2018

National clinical guidelines website falls to budget cuts

The Agency for Healthcare Research and Quality (AHRQ) will remove its National Guideline Clearinghouse (...

2:58 PM Jul 13, 2018

Siga gets Priority Review voucher for first approved smallpox drug

Siga Technologies Inc. (NASDAQ:SIGA) became the first company to gain FDA approval for a smallpox drug and...

1:22 PM Jul 13, 2018

Amgen, UCB again seeking FDA nod for osteoporosis mAb

A year after receiving a complete response letter for Evenity romosozumab, Amgen Inc. (NASDAQ:AMGN) and...

11:14 AM Jul 13, 2018

Follow-on roundup: Myovant, CytomX, Spero

Myovant Sciences Ltd. (NYSE:MYOV), CytomX Therapeutics Inc. (NASDAQ:CTMX) and Spero Therapeutics Inc. (...

9:24 AM Jul 13, 2018

Advaxis rises after FDA lifts clinical hold

Advaxis Inc. (NASDAQ:ADXS) jumped $0.12 (10%) to $1.34 Friday after it said FDA lifted a clinical hold on...

5:33 PM Jul 12, 2018

MS play Octave adds Scangos to board, raises $14M series A

Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million in a series A...

3:53 PM Jul 12, 2018

ICER panel votes against elagolix for endometriosis

An ICER panel showed little confidence in the clinical effectiveness of elagolix (ABT-620) from AbbVie...

3:23 PM Jul 12, 2018

CMS proposing to cut payments for new Part B drugs

In a proposed rule released Thursday, CMS said it plans to cut Medicare Part B reimbursement for the first...

2:52 PM Jul 12, 2018

Korea: Samsung Biologics violated accounting rules

Korea’s Securities and Futures Commission ruled Thursday that Samsung BioLogics Co. Ltd. (KSE:207940)...

2:34 PM Jul 12, 2018

Oyster Point's nasal spray meets in Phase IIb for dry eye

Oyster Point Pharma Inc. (Princeton, N.J.) said its OC-02 nasal spray met the primary endpoints in the U....

2:30 PM Jul 12, 2018

Congress poised to top Trump funding for NIH, CDC

The House Appropriations Committee approved an appropriations bill on Wednesday that calls for a $1.3...

2:18 PM Jul 12, 2018

FDA to release biosimilars plan July 18

FDA’s Biosimilars Action Plan is likely to include elements the agency has disclosed in recent months...

2:01 PM Jul 12, 2018

Genmab, Immatics in bispecific immunotherapy deal

Immatics Biotechnologies GmbH (Tuebingen, Germany) granted Genmab A/S (CSE:GEN; Pink:GMXAY) exclusive,...

1:51 PM Jul 12, 2018

Virus-free CRISPR T cell editing

A team led by University of California San Francisco researchers developed a non-viral method to engineer...

1:34 PM Jul 12, 2018

Zogenix market cap grows with second Phase III win

Zogenix Inc. (NASDAQ:ZGNX) gained $9.60 (21%) to $55.90 on Thursday, adding about $338 million in market...

12:27 PM Jul 12, 2018

Haitong leads Orig3n's series B

Regenerative medicine company Orig3n Inc. (Boston, Mass.) said it had an initial close of a series B round...

Down Up